LABU
LABU
About Direxion Daily S&P Biotech Bull 3X Shares
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life...
About Direxion Daily S&P Biotech Bull 3X Shares
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 APGE | Apogee Therapeutics, Inc. | 0.77% | 36.60K | $4.90M |
 MRNA | Moderna, Inc. | 0.70% | 65.84K | $4.41M |
 KYMR | Kymera Therapeutics, Inc. | 0.67% | 38.71K | $4.27M |
 VKTX | Viking Therapeutics, Inc. | 0.66% | 109.12K | $4.16M |
 ERAS | Erasca, Inc. | 0.64% | 226.49K | $4.05M |
 TWST | Twist Bioscience Corporation | 0.64% | 44.68K | $4.04M |
 ORKA | Oruka Therapeutics, Inc. | 0.63% | 47.29K | $4.00M |
 CGON | CG Oncology Inc. | 0.63% | 55.14K | $4.00M |
 PRAX | Praxis Precision Medicines, Inc. | 0.62% | 12.58K | $3.96M |
 DNTH | Dianthus Therapeutics, Inc. | 0.62% | 39.62K | $3.91M |
 RVMD | Revolution Medicines, Inc. | 0.61% | 21.00K | $3.86M |
 MIRM | Mirum Pharmaceuticals, Inc. | 0.61% | 32.21K | $3.83M |
 NTRA | Natera, Inc. | 0.60% | 13.98K | $3.82M |
 PCVX | Vaxcyte, Inc. | 0.60% | 66.67K | $3.80M |
 RYTM | Rhythm Pharmaceuticals, Inc. | 0.60% | 35.33K | $3.80M |
 SYRE | Spyre Therapeutics, Inc. | 0.60% | 40.33K | $3.78M |
 SRRK | Scholar Rock Holding Corporation | 0.59% | 68.68K | $3.76M |
 BBIO | BridgeBio Pharma, Inc. | 0.59% | 44.92K | $3.73M |
 PTGX | Protagonist Therapeutics, Inc. | 0.59% | 28.63K | $3.72M |
 CYTK | Cytokinetics, Incorporated | 0.59% | 45.15K | $3.71M |
SECTOR HOLDINGS
Healthcare
Financial ServicesASSET ALLOCATION BY REGION
United States
Ireland
United Kingdom
Switzerland
NetherlandsSECTOR HOLDINGS
Healthcare Financial ServicesASSET ALLOCATION BY REGION
United States Ireland United Kingdom Switzerland NetherlandsHoldings (Top 20)
APGE
Apogee Therapeutics, Inc.
MRNA
Moderna, Inc.
KYMR
Kymera Therapeutics, Inc.
VKTX
Viking Therapeutics, Inc.
ERAS
Erasca, Inc.
TWST
Twist Bioscience Corporation
ORKA
Oruka Therapeutics, Inc.
CGON
CG Oncology Inc.
PRAX
Praxis Precision Medicines, Inc.
DNTH
Dianthus Therapeutics, Inc.
RVMD
Revolution Medicines, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
NTRA
Natera, Inc.
PCVX
Vaxcyte, Inc.
RYTM
Rhythm Pharmaceuticals, Inc.
SYRE
Spyre Therapeutics, Inc.
SRRK
Scholar Rock Holding Corporation
BBIO
BridgeBio Pharma, Inc.
PTGX
Protagonist Therapeutics, Inc.
CYTK
Cytokinetics, Incorporated